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Abstract
We have used double-label in situ hybridization techniques to
examine the cellular localization of GABAB receptor mRNA in
relation to serotonin transporter mRNA and glutamic acid
decarboxylase mRNA in the rat dorsal raphe, median raphe
and raphe magnus nuclei. The degree of cellular co-localiza-
tion of these markers notably varied among the different
nuclei. In the dorsal raphe, cell bodies showing GABAB
receptor mRNA were very abundant, the 85% being also
labelled for serotonin transporter mRNA, and a low proportion
(5%) showing glutamic acid decarboxylase mRNA. In the
median raphe, the level of co-expression of GABAB receptor
mRNA with serotonin transporter mRNA was significantly
lower. Some cells were also identified that contained GABAB
receptor mRNA in the absence of either one of the other
mRNA species studied. Our results support the presence of
GABAB receptors in serotonergic as well as GABAergic
neurones in the dorsal and median raphe, providing the ana-
tomical basis for the reported dual inhibitory/disinhibitory
effect of the GABAB agonist baclofen on serotonergic function.
Keywords: dorsal raphe, double-labeling, GABA, GAD, in situ
hybridization, median raphe.
J. Neurochem. (2003) 84, 743–752.
5-Hydroxytryptamine (serotonin; 5-HT)-containing neurones
are mainly localized in the midbrain and brainstem raphe
nuclei (Dahlstro¨m and Fuxe 1964; Steinbusch 1981) and
project to virtually all regions of the brain, being involved
in a large number of physiological functions (Jacobs and
Azmitia 1992; Leibowitz and Alexander 1998). The electri-
cal activity of 5-HT neurones is under a ﬁne control exerted
by different neurotransmitter systems including, among
others, serotonin itself, noradrenaline, dopamine, histamine,
glutamate, c-aminobutyric acid (GABA), glycine and several
neuropeptides (for review see Jacobs and Azmitia 1992;
Adell et al. 2002). The inhibitory neurotransmitter GABA
plays an essential role in the regulation of 5-HT neurones,
operating through local GABAergic interneurones as well as
distal GABAergic afferents that project to the raphe nuclei
(Gervasoni et al. 2000). Both GABAA and GABAB recep-
tors are present in the raphe (Bowery et al. 1987; Price et al.
1987; Chu et al. 1990; Bischoff et al. 1999) and their
stimulation appears to inhibit ﬁring activity of 5-HT neu-
rones (Gallager and Aghajanian 1976; Innis and Aghajanian
1987). Extra- and intracellular recordings have provided
evidence that stimulation of GABAB receptors hyperpolar-
izes 5-HT neurones through the opening of a voltage-
dependent, pertussis toxin-sensitive, inwardly rectifying
potassium channel coupled to a G protein, which is also
operated by 5-HT1A receptors (Innis and Aghajanian 1987;
Colmers and Williams 1988; Innis et al. 1988; Williams
et al. 1988). This would presuppose the localization of
GABAB receptors in 5-HT neurones bearing 5-HT1A auto-
receptors. Indeed, recent immunohistochemical studies have
demonstrated the co-existence of GABAB receptor-like
immunoreactivity (LI) with serotonergic cell markers in
single raphe neurones (Wirtshafter and Sheppard 2001; Varga
et al. 2002). In accordance with that, microdialysis studies
have shown that under lights-off conditions the infusion of
the GABAB agonist baclofen in the DR diminishes the
release of 5-HT (Tao et al. 1996). However, during the
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lights-on period baclofen infusion in the DR and MnR
increases 5-HT release, indicating a disinhibitory action
(Abella´n et al. 2000b). This view is also supported by
intracellular recordings of dorsal raphe nucleus (DR) 5-HT
neurones in midbrain slices, showing that baclofen at low
concentrations (IC50 ¼ 72 nM) counteracts GABAA-medi-
ated inhibitory post-synaptic currents in 5-HT neurones,
whereas higher concentrations (IC50 ¼ 1.4 lM) are required
to elicit a direct inhibitory effect (Abella´n et al. 2000b).
These data have been interpreted as resulting from a dual
action of baclofen, including an indirect (disinhibitory) effect
mediated through GABAB pre-synaptic autoreceptors located
on GABAergic terminals projecting to serotonergic neu-
rones, and a direct (inhibitory) effect mediated through post-
synaptic GABAB receptors located on 5-HT neurones. This
hypothesis presumes the presence of GABAB receptors in
serotonergic as well as in GABAergic cells.
In order to validate this model we have now examined the
localization of GABAB receptors in relation to 5-HT and
GABAergic cells of the raphe nuclei at different midbrain
and upper pons levels. We have used double in situ
hybridization histochemical techniques to identify the phe-
notype of cells expressing GABAB receptor mRNA using
serotonin transporter (5-HTT) mRNA and glutamic acid
decarboxylase (GAD; EC 4.1.1.15) mRNA as markers of
5-HT and GABAergic cells, respectively.
Preliminary reports of the data have been presented in
abstract form (Serrats et al. 2001, 2002).
Materials and methods
Specimens
Adult male Wistar rats (n ¼ 15, 200–250 g b.w.) were purchased
from Iffa Credo (Lyon, France). Animal care followed the Spanish
legislation on Protection of animals used in experimental and other
scientiﬁc purposes in agreement with European regulations (O.J. of
EC L358/1 18/12/1986). The animals were kept in a controlled
environment (12-h light–dark cycle and 22 ± 2C), with free access
to food and water. The animals were killed by decapitation, the
brains rapidly removed, frozen on dry ice and stored at ) 20C.
Tissue sections, 14 lm thick, were cut using a microtome-cryostat
(Microm HM500 OM, Walldorf, Germany), thaw-mounted onto
slides coated with APTS (3-aminopropyltriethoxysilane, Sigma, St
Louis, MO, USA) and kept at )20C until use.
Hybridization probes
The oligodeoxyribonucleotide probes used were as follows: for the
5-HTT mRNA, two probes were always used together, 5-HTT-probe
1, complementary to bases 51–98, and 5-HTT-probe 2, comple-
mentary to bases 612–659 (Blakely et al. 1991); the probe for GAD
mRNA was complementary to bases 1537–1590 (Kobayashi et al.
1987); the probe used for GABAB-R1 mRNA was a pan probe
which should recognize both GABAB-R1a and GABAB-R1b
subtypes and was complementary to bases 2814–2858 (Kaupmann
et al. 1997). The probes for 5-HTT and GAD mRNA were
synthesized on a 380 Applied Biosystem DNA synthesizer (Foster
City Biosystems, Foster City, CA, USA) and puriﬁed on a 20%
polyacrylamide/8 M urea preparative sequencing gel. The GABAB
receptor mRNA probe was custom synthesized and high-perform-
ance liquid chromatography (HPLC) puriﬁed by Amersham Phar-
macia Biotech (Little Chalfont, UK).
Oligonucleotides were labelled either with 33P or with digoxige-
nin (Dig). For the radioactive method, oligonucleotides (2 pmol)
were 3¢-end-labelled with [33P]a-dATP (> 2500 Ci/mmol; DuPont-
NEN, Boston, MA, USA) using terminal deoxynucleotidyltrans-
ferase (Roche Diagnostics GmbH, Mannheim, Germany), puriﬁed
by centrifugation using QIAquick Nucleotide Removal Kit (Qiagen
GmbH, Hilden, Germany) and eluted in 200 lL of elution buffer.
Alternatively, for the non-radioactive method, 100 pmol of oligo-
nucleotide were labelled by 3¢-end tailing with the same enzyme and
Dig-11-dUTP (Boehringer Mannheim, Mannheim, Germany)
according to a previously described procedure (Schmitz et al.
1991). Dig-labelled oligonucleotides were puriﬁed by ethanol
precipitation and resuspended in 200 lL of 1 · TE (10 mM
Tris–HCl pH 7.5, 1 mM EDTA pH 8.0).
In situ hybridization histochemistry procedure
The protocols for single- and double-label in situ hybridization were
based on previously described procedures (Tomiyama et al. 1997;
Landry et al. 2000). Frozen tissue sections were ﬁrst brought to
room temperature, ﬁxed for 20 min at 4C in 4% paraformaldehyde
in phosphate-buffered saline (1 · PBS: 8 mM Na2HPO4, 1.4 mM
KH2PO4, 136 mM NaCl, 2.6 mM KCl), washed for 5 min in 3 ·
PBS at room temperature, twice for 5 min each in 1 · PBS, and
incubated for 2 min at 21C in a fresh solution of pre-digested
pronase (Calbiochem, San Diego, CA, USA) at a ﬁnal concentration
of 24 U/mL in 50 mM Tris–HCl pH 7.5, 5 mM EDTA. The enzy-
matic activity was stopped by immersion for 30 s in 2 mg/mL
glycine in 1 · PBS. Tissues were ﬁnally rinsed in 1 · PBS and
dehydrated through a graded series of ethanol.
For hybridization, the radioactively labelled and/or the non-
radioactively labelled probes were diluted in a solution containing
50% formamide, 4 · SSC (1 · SSC: 150 mM NaCl, 15 mM sodium
citrate), 1 · Denhardt’s solution (0.02% Ficoll, 0.02% polyvinyl-
pyrrolidone, 0.02% bovine serum albumin), 10% dextran sulphate,
1% sarkosyl, 20 mM phosphate buffer pH 7.0, 250 lg/mL yeast
tRNA and 500 lg/mL salmon sperm DNA. The ﬁnal concentrations
of radioactive and Dig-labelled probes in the hybridization buffer
were in the same range (approximately 1.5 nM). Tissue sections
were covered with hybridization buffer containing the labelled
probe(s), overlaid with Nescoﬁlm coverslips (Bando Chemical Ind,
Kobe, Japan) and incubated overnight at 42C in humid boxes. The
sections were then washed four times (15 min each) in 1 · SSC at
55C, and once in 1 · SSC at room temperature for 30 min.
Development of radioactive and non-radioactive hybridization
signal
Slides that had been hybridized only with [33P]-labelled probes were
directly dehydrated through ethanols and allowed to air dry. In
parallel, sections hybridized with Dig-labelled probe(s) were treated
as described by Landry et al. (2000). Thus, after washing, the slides
were immersed for 30 min in a buffer containing 0.1 M Tris–HCl
pH 7.5, 1 M NaCl, 2 mM MgCl2 and 0.5% bovine serum albumin
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(Sigma) and incubated overnight at 4C in the same solution
with alkaline-phosphate-conjugated antidigoxigenin-F(ab) frag-
ments (1 : 5000; Boehringer Mannheim). Afterwards, they were
washed three times (10 min each) in the same buffer (without
antibody), and twice in an alkaline buffer containing 0.1 M Tris–HCl
pH 9.5, 0.1 M NaCl and 5 mM MgCl2. Alkaline phosphatase activity
was developed by incubating the sections with 3.3 mg nitroblue
tetrazolium and 1.65 mg bromochloroindolyl phosphate (Gibco–
BRL, Gaithersburg, MD, USA) diluted in 10 mL of alkaline buffer.
The enzymatic reaction was stopped by extensive rinsing in the
alkaline buffer supplemented with 1 mM EDTA. The sections were
then brieﬂy dipped in 70% and 100% ethanol and air-dried.
Sections incubated with radioactive probes (alone or in combi-
nation with Dig-labelled oligonucleotides) were dipped into Ilford
K5 nuclear emulsion (Ilford, Mobberly, Chesire, UK) diluted 1 : 1
with distilled water. The sections were exposed in the dark at 4C
for 1 week, and ﬁnally developed in Kodak D19 (Kodak, Rochester,
NY, USA) for 5 min, and ﬁxed in Ilford Hypam ﬁxer (Ilford).
Specificity of the probes
Several control experiments were carried out to determine the
speciﬁcity of the hybridization signal: (i) the thermo-stability of
hybrids obtained was checked for every probe; (ii) for a given
oligonucleotide probe, the hybridization signal was completely
blocked by competition of the labelled probe in the presence of
50-fold excess of the same unlabelled oligonucleotide; (iii) to assure
the speciﬁcity of the non-radioactive hybridization signal, we
compared the results obtained with the same probe radioactively
labelled.
Analysis of the results
Tissue sections were examined in bright- and dark-ﬁeld in a Wild
420 macroscope (Leica, Heerbrugg, Germany) and in a Nikon
Eclipse E1000 microscope (Nikon, Tokyo, Japan) equipped with
bright- and dark-ﬁeld condensers for transmitted light and with epi-
illumination. Micrography was performed using a digital camera
(DXM1200 3.0, Nikon) and analySIS Software (Soft Imaging
System GmbH, Mu¨nster, Germany). Bright- and dark-ﬁeld images
were captured with transmitted light. Alternatively, silver grains in
the emulsion layer were visualized with epi-illumination passing
through a ﬁlter (pol-cube) that selects for polarized light reﬂected off
the silver grains and captured as a separated image. The pol image
was inverted with Adobe Photoshop software (Adobe Software,
Mountain View, CA, USA). The ﬁgures were prepared for
publication using Adobe Photoshop software.
Cell counting was performed manually at the microscope with the
help of analySIS Software. Analysis of variance and post-hoc
Tukey’s test were performed using GraphPad Prism software
(GraphPad Software, San Diego, CA, USA). A p-value < 0.05
was considered statistically signiﬁcant.
Results
The presence of 5-HTT, GAD and GABAB mRNA in cells of
the DR, median raphe nucleus (MnR) and raphe magnus
(RMg) of the rat was examined at 11 different antero-
posterior coronal levels comprised between planes ) 7.0 and
) 9.3 mm from bregma (Paxinos and Watson 1998). A
macroscopic view of the localization of these three mRNA
species in the DR and MnR at level 4 (approx. ) 8.3 mm
from bregma) is illustrated in Fig. 1. Within the MnR, two
separate populations of cells were recognized, according to
their anatomical location, morphological characteristics and
mRNA content (see below). We will designate these two
subnuclei as dorsal (dMnR) and ventral (vMnR) portions of
the MnR (see Fig. 1).
Fig. 1 Macroscopic dark-field images from serial coronal sections of
the rat midbrain showing the radioactive labeling of mRNAs encoding
5-HTT (a), GABAB receptor (b) and GAD (c and d). (a) Abundant
5-HTT mRNA labeling is observed in the dorsal raphe (DR) and dorsal
(dMnR) and ventral (vMnR) parts of the median raphe. (b) GABAB
receptor mRNA is also detected in the DR. (c) Very strong GAD mRNA
labeling can be seen in the inferior colliculus (IC), dorsal nucleus of the
lateral lemniscus (DLL) and areas surrounding the raphe nuclei such
as the ventral tegmental nucleus (VTg) and cells in the medial longi-
tudinal fasciculus (mlf). Positive cells in the raphe nuclei are not clearly
discernible at this magnification. (d) Detail from section in (c), showing
numerous cells containing GAD mRNA, in the ventromedial portion of
the DR. Some heavily labelled cells (arrowheads) are abundant in the
ventrolateral edges of the nucleus, while in cells located more dorsally
in the DR, the hybridization signal is weaker (open arrowheads).
Bar ¼ 1 mm (a and c), 100 lm (b and d).
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The three mRNA species were labelled in tissue sections
using either radioactive or non-radioactive probes. Both
methods yielded identical results concerning the average
number of positive cells and their local distribution. When
[33P]- and Dig-labelled probes were used simultaneously in
double in situ hybridization assays, the radioactive signal
obtained (density of silver grains per cell) was clearly weaker
than in single [33P]-probe assays. In contrast, no clear-cut
differences in signal intensity could be observed for Dig-
labelled oligonucleotides when used alone or in combination
with radioactive probes.
Distribution of 5-HTT mRNA
A strong 5-HTT mRNA signal was observed in the DR, MnR
and RMg (see Fig. 1a). Most 5-HTT mRNA-positive cells
were located within the boundaries of the DR, which
contained between 70 and 480 labelled cell bodies per
section, depending on the level. 5-HTT mRNA expressing
cells in the DR were densely packed in the dorsomedial and
ventromedial parts of the nucleus, and showed a more
scattered distribution in its lateral wings. The ventromedial
part of the DR contained the largest number of positive cell
bodies in the DR. 5-HTT mRNA-labeling (either radioactive
or non-radioactive) per cell in the MnR and RMg was lighter
than in the DR. In the MnR, positive perikarya were grouped
in two clusters: the dorsal (dMnR) and the ventral (vMnR)
groups (see Fig. 1a), whereas in the RMg, positive cells were
dispersed throughout the nucleus. Besides the raphe nuclei,
sparse cell proﬁles presenting also 5-HTT mRNA hybrid-
ization signals were seen in the reticular formation of the
pons and lowest midbrain.
Distribution of GABAB receptor mRNA
GABAB receptor transcript (Fig. 1b) was visualized in the
DR, MnR and RMg using either [33P]- or Dig-labelled
probes. The strongest GABAB receptor mRNA signal
corresponded to the DR, both in terms of number of positive
cells and intensity of labeling. Besides the raphe nuclei, in
the sections examined, very strong GABAB receptor mRNA
signal was also seen in Purkinje cells of the cerebellum (not
shown). Weaker labeling was observed in the periaqueductal
gray, inferior colliculus, granule cell layer of the cerebellum
and cerebral cortex (not shown).
Distribution of GAD mRNA
In the brain sections analysed, a strong GAD mRNA
hybridization signal was found in the superﬁcial gray layer
of the superior colliculus, inferior colliculus, dorsal nucleus
of the lateral lemniscus and Purkinje cells (not shown).
Lower levels of GAD mRNA were present in many other
structures such as the neocortex, molecular layer of the
cerebellum and areas surrounding the DR and MnR (inclu-
ding the ventral tegmental nucleus, medial longitudinal
fasciculus and periaqueductal gray, among others). Within
the raphe nuclei, GAD mRNA-containing cells could be
identiﬁed in the DR (Figs 1c and d), MnR and RMg. Positive
cells were most abundant in the ventrolateral portion of the
DR and in its lateral parts. In the DR and MnR we could
clearly distinguish two types of labelled cells, depending on
the degree (intermediate or low) of GAD mRNA expression.
Co-localization of 5-HTT mRNA and GABAB receptor
mRNA (Figs 2a–c and 3)
The coexistence of GABAB receptor mRNA and 5-HTT
mRNA in the DR, MnR and RMg was examined by double
in situ hybridization using two [33P]-labelled probes for
5-HTT and a Dig-labelled probe for GABAB receptor mRNA
in the coronal levels selected. The number of cells labelled
for GABAB receptor mRNA and double-labelled cells
counted in these nuclei are summarized in Fig. 3.
In the DR (Figs 2a and 3a), 84 ± 6% (mean ± SD) of the
cells presenting GABAB receptor mRNA signal were found
to co-express 5-HTT mRNA. Thus, approximately 15% of
GABAB receptor mRNA-positive cells in the DR were
devoid of 5-HTT mRNA signal. The proportions of single-
versus double-labelled cells did not display signiﬁcant
differences along the rostro-caudal axis.
In the MnR, the dMnR and vMnR parts were analysed
independently. In the dMnR, 72 ± 14% of the GABAB
receptor mRNA-positive cells also contained 5-HTT mRNA,
whereas in the vMnR the degree of co-expression was lower
(50 ± 10%). The differences among the DR, dMnR and
vMnR concerning the ratios of double-labelled cells versus
GABAB receptor mRNA-positive cells were highly signiﬁ-
cant (one-way ANOVA, p < 0.0001). Tukey’s post-hoc test
indicated statistically signiﬁcant differences (p < 0.001) in
all pair comparisons (DR vs. vMnR; DR vs. dMnR; vMnR
vs. dMnR). In neither the DR nor the MnR could we detect
cells that expressed 5-HTT mRNA in the absence of GABAB
receptor mRNA.
Finally, we analysed the expression of 5-HTT and GABAB
receptor mRNA in the RMg. In this nucleus we identiﬁed
5–10 cells positive for 5-HTT mRNA in each section, which
did not express GABAB receptor mRNA in most cases. Only
in a few sections could single cells be identiﬁed which
co-expressed both mRNAs.
Co-localization of GAD mRNA and GABAB receptor
mRNA (Figs 2d–f and 4)
The co-existence of GAD mRNA and GABAB receptor
mRNA was examined using a [33P]-labelled probe for GAD
mRNA and Dig-labelled probe for GABAB receptor mRNA.
In the raphe nuclei, few double-labelled cells could be
identiﬁed, which accounted for 5.82 ± 2.17% of the total
population of GABAB receptor mRNA-containing cells in
the DR (Fig. 4). A similar situation was observed in the MnR
and RMg, although a quantitative analysis was not performed
in these nuclei due to the difﬁculties in determining their
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precise limits in the absence of serotonergic markers. We
could not unequivocally identify GAD mRNA-positive cells
devoid of GABAB receptor mRNA signal within the raphe
nuclei examined. This type of cell was present in the
periaqueductal gray, where GAD mRNA could be found with
or without GABAB receptor mRNA. In other midbrain
regions, such as the dorsal nucleus of the lateral lemniscus
and inferior colliculus, abundant GAD mRNA-containing
cells were found, without detectable GABAB receptor
mRNA signal.
Co-localization of GAD mRNA and 5-HTT mRNA
(Figs 2g–j)
Double detection of GAD mRNA and 5-HTT mRNA was
carried out using a [33P]-labelled probe for GAD mRNA and
two Dig-labelled probes for 5-HTT mRNA. We were unable
to clearly identify GAD/5-HTT mRNA double-labelled cells
in the DR and MnR. In contrast, in the RMg, we could ﬁnd
Dig-labelled cell bodies that presented concomitant radio-
active labeling. These double-labelled cells were scarce (only
1–2 per section), representing the 15–25% of 5-HTT mRNA-
positive cells in the RMg, and were mainly located in the
central portion of the nucleus, and occasionally in its lateral
parts.
Co-localization of GAD mRNA, GABAB receptor
mRNA and 5-HTT mRNA (Fig. 5)
GAD mRNA, GABAB receptor mRNA and 5-HTT mRNA
were simultaneously labelled using [33P]-labelled probes for
GAD and 5-HTT mRNA, and Dig-labelled probe for
GABAB receptor mRNA. Using this approach, we intended
to visualize cells expressing GABAB receptor mRNA that
were neither serotonergic nor GABAergic. As shown in
Fig. 5, we could detect some cells presenting GABAB
receptor mRNA hybridization signal, which were devoid of
noticeable radioactive labeling.
Discussion
We have examined the distribution of cells containing
GABAB receptor mRNA, GAD mRNA and 5-HTT mRNA
in the rat DR, MnR and RMg. The use of double-label in situ
hybridization has allowed us to analyse in detail the
co-localization of these mRNAs in cells of the serotonergic
nuclei of the midbrain and upper pons. The present study is a
step further in the knowledge of the expression of GABA-
ergic markers in the raphe nuclei and extends previous
studies from this laboratory on the occurrence of those
mRNA species in the DR and MnR (Abella´n et al. 2000a).
Fig. 2 Photomicrographs illustrating the simultaneous detection of
different mRNA species using [33P]-labelled oligonucleotides (silver
grains) and Dig-labelled oligonucleotides (dark precipitate). Open
arrowheads point to Dig-labelled cell profiles, filled arrowheads point to
radioactively labelled cell profiles, arrows point to double-labelled cells.
(a–f) Bright field images show GABAB receptor mRNA (dark precipi-
tate) in combination with radioactive labeling of 5-HTT mRNA (a–c) or
GAD mRNA (d–f) in the DR (a and d), dMnR (b and e) and vMnR
(c and f). (g–j) Images show 5-HTT mRNA (dark precipitate) in
combination with radioactive labeling of GAD mRNA, in the DR (g),
MnR (h) and RMg (i and j). Bright field (i) and inverted polarized-light
image (see text for details, j) from the same field in RMg showing
co-localization of 5-HTT mRNA and GAD mRNA. Bars: (a–f) bar in
(a) ¼ 20 lm; (i and j), bar in (i) ¼ 20 lm.
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Our reults concerning the cellular localization of 5-HTT,
GABAB receptor and GAD mRNA in the rat raphe nuclei are
in good agreement with published data. As expected, 5-HTT
mRNA hybridization signal in the mesencephalon and upper
pons was essentially restricted to the raphe nuclei. Thus,
5-HTT mRNA signal was strong in cell bodies in the DR,
MnR and RMg, as it has been shown previously in rat, mouse,
cat and humans (Fujita et al. 1993; Rattray et al. 1994, 1999;
Charnay et al. 1996; McLaughlin et al. 1996; Bengel et al.
1997). In accordance with those studies, the highest densities
of 5-HTT mRNA corresponded to the DR. We could also
detect 5-HTT mRNA in cells scattered throughout the
pontomesencephalic reticular formation, presumably 5-HT-
containing neurones present in this area (Vertes and Crane
1997). The localization of 5-HTT mRNA-positive cell
proﬁles observed here entirely correlates with the known
location of serotonergic cell bodies (Dahlstro¨m and Fuxe
1964; Steinbusch 1981; Rattray et al. 1999). Despite the fact
that 5-HTT mRNA has been detected in cultured astrocytes
and in adult rat forebrain using RT–PCR (Bel et al. 1997), in
our preparations we did not observe 5-HTT mRNA hybrid-
ization patterns that could correspond to glia. According to
Rattray et al. (1999), 5-HTT mRNA is exclusively expressed
in serotonergic neurones, and furthermore, virtually all
Fig. 5 Triple-labeling in situ hybridization with [33P]-labelled oligonu-
cleotide probes complementary to 5-HTT mRNA and GAD mRNA
(silver grains) and Dig-labelled oligonucleotide probe complementary
to GABAB receptor mRNA (dark precipitate). (a) Dark-field image
showing intense radioactive labeling in the DR and MnR (dMnR and
vMnR portions) corresponding to 5-HTT plus GAD mRNA. (b and c)
Bright-field micrographs displaying single-labelled versus double-
labelled cells in the DR (b) and MnR (c). Arrows point to cells showing
non-radioactive and radioactive signal. Open arrowheads point to
Dig-labelled cell profiles (GABAB receptor mRNA), demonstrating the
existence of GABAB receptor mRNA-positive cells which do not
express neither 5-HTT mRNA nor GAD mRNA. Bars: 1 mm (a) and
20 lm (b and c).
(a)
(b)
(c)
Fig. 3 Degree of co-localization of GABAB receptor mRNA with 5-HTT
mRNA in the DR (a), dorsal MnR (b) and ventral MnR (c). Bars indi-
cate the total number of cell profiles expressing GABAB receptor
mRNA ( ) or double-labelled cell profiles (h) per section. Cells were
counted in 14 lm-thick coronal sections taken at 10 different antero-
posterior levels (1–10). Data are mean ± SD and were obtained from
three animals.
Fig. 4 Degree of co-localization of GABAB receptor mRNA with GAD
mRNA in the DR. Bars indicate the total number of cell profiles
expressing GABAB receptor mRNA ( ) or double-labelled cell profiles
(h) per section. Cells were counted in 14 lm-thick coronal sections
taken at anatomical levels 3–11, as described. Data are mean ± SD
and were obtained from three animals.
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5-HT-containing neurones contain 5-HTT mRNA (but see
Brown and Molliver 2000). Therefore, the presence of
speciﬁc 5-HTT mRNA hybridization signal can be considered
as a speciﬁc marker of serotonergic phenotype.
In addition to 5-HTT mRNA, the raphe nuclei are well
known to contain high concentrations of 5-HT transporter
protein, as evidenced by ligand binding autoradiography
(Rainbow et al. 1982; Dawson and Wamsley 1983; D’Amato
et al. 1987), and more recently using immunohistochemical
methods (Sur et al. 1996).
The DR showed also a prominent signal for GABAB
receptor mRNA. This is in agreement with published studies
reporting high levels of expression of GABAB receptor
mRNA in monoaminergic regions of the brainstem, inclu-
ding the DR (Bischoff et al. 1999; Lu et al. 1999; Abella´n
et al. 2000a). In fact, the DR has been reported to be one of
the regions most enriched in GABAB receptor mRNA in the
rat brain (Bischoff et al. 1999; Lu et al. 1999). According to
these authors the signal we observed in the DR would
primarily correspond to the GABAB-R1a mRNA subtype,
which appears to be more abundant in this region, although it
also contains the GABAB-R1b subtype. The presence of
GABAB receptor binding sites in the raphe nuclei is well
established, as shown by receptor autoradiography with
[3H]GABA or [3H]baclofen as ligands (Bowery et al. 1987;
Price et al. 1987; Chu et al. 1990; Bischoff et al. 1999).
Immunohistochemical studies have also shown very intense
GABAB-R1-LI in cell bodies in the DR and MnR (Margeta-
Mitrovic et al. 1999; Wirtshafter and Sheppard 2001; Varga
et al. 2002). Thus, there is a good correlation between
GABAB binding sites, GABAB-LI and GABAB mRNA in
the raphe nuclei of the midbrain and upper pons, indicating
that the GABAB receptor can be, at least in part, of local
origin in these nuclei.
Two isoforms of GAD, namely GAD65 and GAD67, have
been identiﬁed, which are encoded by different genes
(Kobayashi et al. 1987; Wyborski et al. 1990; Erlander
et al. 1991). The mRNAs coding for the two GADs present a
very close regional distribution in the brain and, in the rat,
almost all GABA neurones contain mRNA for both GAD65
and GAD67 (Feldblum et al. 1993; Esclapez et al. 1994). In
the present work we have visualized GABAergic neurones
using a probe against GAD67 mRNA because in general it
appears to be more abundant than GAD65 mRNA (Esclapez
et al. 1994). The distribution observed in the sections
examined is in good agreement with previous studies
reporting GAD67 mRNA in the cerebellum, particularly in
Purkinje cells, and structures such as the inferior colliculus
and nucleus raphe magnus (Wuenschell et al. 1986; Julien
et al. 1987; Esclapez et al. 1993, 1994; Feldblum et al.
1993; Stornetta and Guyenet 1999). Our data are also in
accordance with immunohistochemical studies which have
revealed the presence of GAD-LI and GABA-LI in the
brainstem raphe nuclei of the rat, mainly in cells clustered in
the lateral portions of the DR (Nanopoulos et al. 1982; Belin
et al. 1983; Mugnaini and Oertel 1985; Millhorn et al. 1987,
1988; Kachidian et al. 1991; Wang and Nakai 1993;
Esclapez et al. 1994; Ford et al. 1995; Stamp and Semba
1995; Gervasoni et al. 2000).
When comparing the expression of 5-HTT, GABAB
receptor and GAD mRNA in the raphe nuclei, the most
abundant mRNA species in terms of number of labelled cells
was the GABAB receptor mRNA. Conversely, GAD mRNA
was present only in a reduced number of raphe cells and it
was mainly found beyond the boundaries of the raphe nuclei.
By using double in situ hybridization we have visualized
the presence of GABAB receptor mRNA in different
populations of cells within the raphe nuclei, including
serotonergic (5-HTT mRNA-positive), GABAergic (GAD
mRNA-positive) and also a minority of non-serotonergic
non-GABAergic cells. One of our goals has been to evaluate
the proportions of single- versus double-labelled cells within
the raphe nuclei.
The degree of coexistence of GABAB receptor and 5-HTT
mRNAs in the raphe signiﬁcantly varied from one nucleus to
the other. Thus, whereas in the DR and MnR all serotonergic
neurones exhibited GABAB receptor mRNA signal, in the
RMg these mRNA species were rarely found together.
Double-labelled cells represented a large proportion (84%) of
GABAB receptor mRNA-positive cells of the DR. This ratio
remained constant among the different cell groups (ventral
and dorsal portions and lateral wings) and along the
rostrocaudal extent of the nucleus. In contrast, in the MnR,
we could discriminate between two groups of GABAB
receptor mRNA-positive cells: a ventral cluster (vMnR)
where only the 50% of cells co-expressed 5-HTT mRNA,
and a dorsal group (dMnR) with characteristics closer to the
DR. Cytoarchitectural differences between cells located in
the dorsal and ventral portions of the MnR have been
described before (Vertes and Crane 1997).
In addition to serotonergic cells, GABAB receptor mRNA
was also detected in all GAD mRNA-positive cell proﬁles
visualized within the boundaries of the raphe nuclei studied
here. This ﬁnding suggests that all GABAergic neurones in
the raphe express GABAB autoreceptors. This is in agree-
ment with data from Liang et al. (2000) who reported that all
GABA neurones in the rat brain contain GABAB receptor
mRNA, with the unique exception of the dorsal lateral
geniculate nucleus. However, it should be mentioned that in
the tissue sections examined here we could observe GAD
mRNA in cells apparently devoid of GABAB receptor
mRNA in structures such as the periaqueductal gray, dorsal
nucleus of the lateral lemniscus or the inferior colliculus.
These midbrain nuclei were not the focus of the present study
and were not exhaustively examined. It should be noted also
that limitations in the sensitivity of our in situ hybridization
method might hinder the visualization of mRNAs present in
low densities.
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It has been shown that GABA-immunoreactive terminals
contact 5-HT neurones in the DR (Wang et al. 1992). This
observation together with the present data showing the
occurrence of GABAB receptor mRNA in both or 5-HTT
mRNA-positive and GAD-containing cells in the raphe
nuclei provides anatomical support to the hypothesis
expressed by Abella´n et al. (2000b) to explain the dual
effect of the GABAB agonist baclofen on 5-HT cells. Thus,
post-synaptic GABAB receptors located on serotonergic
neurones could mediate the inhibition of 5-HT release
caused by baclofen (Tao et al. 1996), whereas the activation
of pre-synaptic GABAB receptors located in GABAergic
cells would result in a ﬁnal disinhibitory action on seroto-
nergic neurones (Abella´n et al. 2000a, 2000b). It should be
pointed out that, according to our observations, GAD/
GABAB receptor mRNA-containing cells in the raphe nuclei
are not abundant. Therefore the reported pre-synaptic
GABAB effects are likely to be mediated mainly by receptors
located in nerve terminals from afferent GABAergic projec-
tion neurones. It has been demonstrated that the DR receives
GABAergic inputs both from local interneurones located in
the DR itself and periaqueductal gray and from neurones
located in distant regions from the forebrain to the medulla
(Gervasoni et al. 2000).
In this study we show the existence of GABAB receptor
mRNA-positive cells in the DR that do not display 5-HTT
nor GAD mRNA hybridization signal, and therefore appear
to be neither GABAergic, nor serotonergic. Such cells can be
part of other neurochemical identities which have been
described within the boundaries of the raphe nuclei, such as
dopaminergic neurones (Bjo¨rklund and Ho¨kfelt 1984), nitric-
oxide containing neurones (Xu and Ho¨kfelt 1997; Le´ger
et al. 1998), or neuropeptide-containing neurones (Kiriﬁdes
et al. 2001). For instance, GABAB receptor-LI has been
shown in tyrosine hydroxylase immunoreactive cell bodies of
the DR (Wirtshafter and Sheppard 2001).
Our double-label experiments showed also the co-exist-
ence of GAD mRNA and 5-HTT mRNA in single raphe
cells. The co-localization of these two mRNAs was limited to
the RMg, and we have not been able to unequivocally detect
such double-labelled cells in the DR and MnR. The presence
of GABAergic markers in DR and MnR 5-HT neurones is
controversial as different authors have reported discrepant
results from immunohistochemical studies (Nanopoulos
et al. 1982; Belin et al. 1983; Kachidian et al. 1991; Wang
et al. 1992). In an attempt to clarify this issue, Stamp and
Semba (1995) have quantiﬁed cells immunoreactive for both
5-HT and GAD in the rat brainstem and found very few
5-HT/GAD double-labelled cells in the DR and MnR,
accounting for less than 1% of all 5-HT-stained neurones
in these nuclei. The present data essentially agree with the
view that a very small proportion of 5-HT cells – if any – also
express GAD. Experimental factors (e.g. different technical
approaches, additional presence of GAD65, use of colchi-
cine; Corte´s et al. 1990) may account for this small
difference.
In contrast, a substantial percentage of cells in the RMg
(15–25%) were 5-HTT/GAD mRNA double-labelled, con-
sistently with previous ﬁndings. Thus, the co-existence of
5-HT with GABA or GAD is well documented from
immunohistochemical studies (Belin et al. 1983; Millhorn
et al. 1987, 1988; Kachidian et al. 1991; Stamp and Semba
1995). This percentage is considerably higher than that
reported by Stamp and Semba (1995) who found GAD-LI in
less than 4% of 5-HT neurones, but is closer to data from
Millhorn et al. (1988). The RMg is an important component
of the antinociceptive system (Basbaum and Fields 1978),
and in particular, on the basis of retrograde transport studies
showing projections of 5-HT/GABA neurones to the spinal
cord, it has been speculated that these neurones might have a
role in the modulation of nociception (Millhorn et al. 1987).
In conclusion, we have detected the presence of GABAB
receptor mRNA in serotonergic and also in GABAergic cells
in the raphe nuclei, a ﬁnding that provides the anatomical
basis for the dual effect of baclofen on the serotonergic
neurones observed in electrophysiological and microdialysis
studies. We have also visualized DR neurones expressing
GABAB receptor mRNA which are neither serotonergic nor
GABAergic. Our ﬁndings emphasize also the neurochemical
diversity of the different raphe nuclei, as we demonstrate
distinct patterns of co-expression of 5-HTT mRNA, GABAB
receptor mRNA and GAD mRNA in the DR, MnR and RMg.
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